Sun Pharmaceutical Industries Limited has released its Sustainability Report for the financial year 2024-25. The report highlights the company’s ESG performance and its commitment to sustainable practices. The report is available on the company’s website and outlines the company’s environmental and social initiatives, along with its governance framework. External assurance was provided by DNV.
Commitment to Sustainability
Sun Pharmaceutical Industries Limited has issued its Sustainability Report for the financial year 2024-25. The report showcases the company’s performance and ongoing initiatives in the areas of Environment, Social responsibility, and Governance. The company’s sustainability strategy is deeply integrated into its business operations.
Environmental Highlights
The report highlights a 21% reduction in absolute Scope 1 and Scope 2 carbon emissions compared to the baseline year 2020, and a 48% decrease in specific intensity for Scope 1 and Scope 2 carbon emissions. Additionally, the company achieved a 25% reduction in absolute water consumption and sources 41% of its energy from renewable sources.
Social Impact
In FY25, Sun Pharma invested ₹1,424 Million in CSR initiatives, impacting over 1 Mn+ lives in India through health, education, and other community programs.
Governance Performance
The report highlights strong governance with a 92.9% average Board meeting attendance and 62.5% Independent Board Directors.
Reporting Details
The Sustainability Report is prepared with reference to the GRI Standards 2021 and aligns with the UN Global Compact principles and TCFD recommendations. The reporting boundary covers 79% of Sun Pharma’s national and international operating sites. The report has received external assurance from DNV.
Source: BSE
